SE7709482L - Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat - Google Patents

Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat

Info

Publication number
SE7709482L
SE7709482L SE7709482A SE7709482A SE7709482L SE 7709482 L SE7709482 L SE 7709482L SE 7709482 A SE7709482 A SE 7709482A SE 7709482 A SE7709482 A SE 7709482A SE 7709482 L SE7709482 L SE 7709482L
Authority
SE
Sweden
Prior art keywords
formula
amino
reacting
amidoxime
amidoximi
Prior art date
Application number
SE7709482A
Other languages
English (en)
Other versions
SE435280B (sv
Inventor
K Takacs
P Literati
I Kiss
A Simay
M Szentivanyi
S Virag
K Farago
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SE7709482L publication Critical patent/SE7709482L/sv
Publication of SE435280B publication Critical patent/SE435280B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7709482A 1976-08-27 1977-08-23 Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat SE435280B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76CI1682A HU177578B (en) 1976-08-27 1976-08-27 Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives

Publications (2)

Publication Number Publication Date
SE7709482L true SE7709482L (sv) 1978-02-28
SE435280B SE435280B (sv) 1984-09-17

Family

ID=10994625

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7709482A SE435280B (sv) 1976-08-27 1977-08-23 Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat

Country Status (23)

Country Link
JP (1) JPS5350131A (sv)
AT (1) AT355554B (sv)
AU (1) AU521432B2 (sv)
BE (1) BE858134A (sv)
CA (1) CA1077506A (sv)
CH (1) CH630344A5 (sv)
CS (1) CS204008B2 (sv)
DD (1) DD132433A5 (sv)
DE (1) DE2738589A1 (sv)
DK (1) DK150196C (sv)
ES (1) ES462346A1 (sv)
FI (1) FI68396C (sv)
FR (1) FR2362845A1 (sv)
GB (1) GB1582029A (sv)
GR (1) GR63623B (sv)
HU (1) HU177578B (sv)
IL (1) IL52804A (sv)
NL (1) NL187478C (sv)
NO (1) NO144793C (sv)
PL (1) PL107628B1 (sv)
SE (1) SE435280B (sv)
SU (1) SU730296A3 (sv)
YU (2) YU202377A (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849522A (en) * 1983-11-03 1989-07-18 Merrell Dow Pharmaceuticals Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
ZA848428B (en) * 1983-11-03 1985-06-26 Merrell Pharma Inc Novel alkoxyimino ether derivatives of 5-acyl-2(1h)-pyridiones
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
JPH01169445A (ja) * 1987-12-25 1989-07-04 Fuji Photo Film Co Ltd 焦点距離切換えカメラ
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes
HU222994B1 (hu) 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
HUP9602204D0 (en) * 1996-08-09 1996-10-28 Biorex Rt Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells
EP1077957B1 (en) 1998-05-11 2004-08-04 Takeda Chemical Industries, Ltd. Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
AU5296799A (en) * 1998-08-03 2000-02-28 N-Gene Kutato Kft. Pharmaceutical compositions against autoimmune diseases
RU2320330C2 (ru) 2002-01-11 2008-03-27 СиУайТиАрЭкс КОРПОРЕЙШН Производные карбоксамидина и их использование при лечении заболеваний сосудов
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
KR20230128462A (ko) 2020-11-19 2023-09-05 제브라 덴마크 에이/에스 아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정

Also Published As

Publication number Publication date
FI772551A7 (fi) 1978-02-28
AU521432B2 (en) 1982-04-01
ATA605477A (de) 1979-08-15
NO144793C (no) 1981-11-11
DK150196C (da) 1987-07-06
NO144793B (no) 1981-08-03
FI68396C (fi) 1985-09-10
GB1582029A (en) 1980-12-31
DK150196B (da) 1987-01-05
JPS5350131A (en) 1978-05-08
SE435280B (sv) 1984-09-17
NO772958L (no) 1978-02-28
NL7709276A (nl) 1978-03-01
AU2825477A (en) 1979-03-01
NL187478C (nl) 1991-10-16
FI68396B (fi) 1985-05-31
JPS6216942B2 (sv) 1987-04-15
CA1077506A (en) 1980-05-13
DD132433A5 (de) 1978-09-27
CH630344A5 (en) 1982-06-15
PL107628B1 (pl) 1980-02-29
ES462346A1 (es) 1978-06-16
DE2738589A1 (de) 1978-03-02
YU202377A (en) 1983-12-31
IL52804A (en) 1981-06-29
SU730296A3 (ru) 1980-04-25
CS204008B2 (en) 1981-03-31
FR2362845A1 (fr) 1978-03-24
AT355554B (de) 1980-03-10
HU177578B (en) 1981-11-28
BE858134A (fr) 1977-12-16
GR63623B (en) 1979-11-27
FR2362845B1 (sv) 1981-01-09
DK379777A (da) 1978-02-28
YU237782A (en) 1983-12-31
IL52804A0 (en) 1977-10-31

Similar Documents

Publication Publication Date Title
SE7709482L (sv) Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat
GB1058606A (en) Novel hydroquinone derivatives for use as photographic developing agents
MX152556A (es) Procedimiento para preparar eteres a base de polialquil-1-oxadiazespirodecano
DK156719C (da) Analogifremgangsmaade til fremstilling af 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphanforbindelser eller syreadditionssalte deraf
ES500822A0 (es) Procedimiento de preparar derivados propanolaminicos
SE7501365L (sv)
SE7702668L (sv) Nya stilbenforeningar och forfarande for deras framstellning
DK305879A (da) R fremgangsmaade til fremstilling af oxadiazolpyrimidinderivate
ES403486A1 (es) Procedimiento para la preparacion de derivados de piperazi-na.
ATE14428T1 (de) Verfahren zur herstellung von bromhaltigen 1,3dioxolen-2-ones.
DK160310C (da) Analogifremgangsmaade til fremstilling af 6-oe(cyclisk amino)ethylaminoaatetrahydrotriazolooe3,4-aaaphthalaziner eller farmaceutisk acceptable syreadditionssalte deraf
GB1512880A (en) 2-substituted-1-(omega-aminoalkoxy) benzenes
SE9702306D0 (sv) Diclavulanate salt with a diamino ether and process of preparation
GB1394356A (en) Process for preparing tris 2-haloalkyl phosphites
ES427433A1 (es) Un procedimiento para preparar un compuesto quimico selec- cionado del grupo que consiste en o-tiocarbamato de nitroi- midazolil-etilo.
ES421182A1 (es) Procedimiento para preparar 1-fenoxi-3-fenoxi-etilamino-2- propanoles.
ES441183A1 (es) Un procedimiento para preparar derivados de fosforotiolato.
Achini et al. Synthesis of pyrrolidines by intramolecular carbanionic epoxide opening
ES419439A1 (es) Procedimiento para la preparacion de nuevos derivados de carbamoil-sulfoxido.
ATE117680T1 (de) Verfahren zur herstellung von gegebenenfalls substituierten ethansulfobetainverbindungen.
SE7609391L (sv) Sett att framstella 1-bensoyl-2-(2',6'-diklorfenylamino)-2-imidazolin och salter derav
GB833008A (en) Improvements in and relating to diquaternary compounds
ES397057A1 (es) Procedimiento para la preparacion de nuevos epoxi-isociana-tos.
ES8105363A1 (es) Procedimiento para la obtencion de colorantes cationicos de hidrazona
ATE200T1 (de) Verfahren zur herstellung von alpha, beta-dihalogenalkylisocyanaten.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7709482-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7709482-9

Format of ref document f/p: F